TuHURA Biosciences, Inc. HURA Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Returns | ||||
| Return on equity | -169.2%— | —— | —— | |
| Efficiency | ||||
| Asset turnover | 0×— | 0×— | 0×— | |
| Liquidity | ||||
| Current ratio | 0.8×-2.9× | 3.7×+2.5× | 1.2×-1.7× | |
| Leverage | ||||
| Debt-to-equity | 0×0.0× | 0×— | —— | |
| Per Share | ||||
| Book value per share | $0.44-44.1% | $0.78+696% | -$0.13— | |
| Valuation | ||||
| Market capitalization | $155.39M+45.8% | $172.94M— | —— | |
| Price / book | 6.7×+1.2× | 11.9×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do TuHURA Biosciences, Inc.'s ratios come from?
- Every ratio is computed from TuHURA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.